Basket trial of reused cancer drugs matched to tumor markers
Treatments studied
Part of Cancer clinical trials.
This trial tests cancer drugs that are already approved for other cancers, chosen based on specific changes found in your tumor. It may help people whose cancer is growing despite standard treatment (or who no longer have standard options).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re over 18 and have a solid tumor, multiple myeloma, or B-cell non-Hodgkin lymphoma that is locally advanced or metastatic and is progressing after standard treatment (or no standard option exists)
- Your general health is good enough to do treatment (ECOG performance status 0 to 2)
- Blood tests and organ function meet minimum levels (for example: white blood cells, hemoglobin, platelets, liver and kidney function)
- Your cancer must be measurable on scans or exams
- You have a recent tumor test showing a change that could match a targeted drug in this study
- Before starting the study drug, you must provide fresh frozen tumor tissue for additional testing (with specific exceptions for some brain tumor cases and certain transplant situations)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial matches people with advanced cancer to a targeted treatment based on a genetic (DNA) or protein (IHC) test from their tumor. It’s for cancers that are no longer responding to standard treatment or where no standard option is available.
This trial tests FDA-approved cancer medicines in people with advanced cancer whose tumor has a specific gene or protein abnormality. It tries to see whether targeting that tumor “fingerprint” can help when standard treatments no longer work.
This trial helps match people with advanced, hard-to-treat cancers to targeted cancer drugs based on lab testing of their tumor. It may help if standard treatment isn’t working or isn’t available, and if your tumor has a “targetable” genetic change.
This trial studies whether giving a targeted cancer medicine based on tumor genetic/protein test results can help people with advanced, incurable cancers live longer. You may be eligible if your cancer has a “potentially actionable” change on testing and you meet health and follow-up requirements.
This trial tests whether matching your tumor’s DNA/RNA results to a specific cancer medicine can work better than standard options when cancer has spread or can’t be removed by surgery. You may be assigned to a “basket” (sub-study) based on the exact changes found in your tumor.
This trial uses genetic testing of your tumor to match you with a targeted therapy. It is for people with advanced solid tumors who have exhausted or cannot tolerate standard treatments.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.